Addiction

Research group

< Neurosciencies Programme

Group Leader

Marta Torrens Melich

This is a multidisciplinary team of health professionals (psychiatrists, psychologists, internist, nurses…) that share clinical, research and teaching activities. In the research area, the main aim is to study addiction to substances from different perspectives to improve secondary prevention and treatment. Main lines of research are: 1) clinical and therapeutic aspects of substance use disorders (opiates, cocaine, alcohol, cannabis…); 2) Psychiatric and infectious (i.e. HIV, HCV) comorbidity in substance use disorders (diagnostic tools, neurobiology); 3) New psychoactive substances of abuse (detection of abuse, potential neurotoxicity); 4) Addictions and gender.

Members

Marta Astals Vizcaino (Technician)

Claudio Guillermo Castillo Buenaventura (Researcher)

Laura Díaz Digón (Researcher)

Adriana Farré Martínez (Technician)

Maria Francina Fonseca Casals (Researcher)

Liliana Galindo Guarin (Researher)

Marc Grifell Guàrdia (Researcher)

Roser Martínez Riera (Researcher)

Diana Martínez Sanvisens (PhD Student)

Paula Karen Mártires (Technician)

Gerard Mateu Codina (PhD Student)

Juan Ignacio Mestre Pintó (Researcher)

Álvaro José Palma Conesa (Researcher)

José Luis Pérez de Heredia Flores (Researcher)

Dídac Prat Lecha (Technician)

Paola Rossi (Researcher)

Claudio Tamarit Francés (Technician)

Judit Tirado Muñoz (Researcher)

Gabriel Vallecillo Sánchez (Researcher)

 

more info

Main Publications

• Galindo L, Pastoriza F, Bergé D, Mané A, Picado M, Bulbena A, Robledo P, Pérez V, Vilarroya O, Cloninger CR. Association between neurological soft signs, temperament and character in patients with schizophrenia and non-psychotic relatives. PeerJ 2016; 4: e1651. IF 2.183. Q1.

• Martinotti G, Orsolini L, Fornaro M, Vecchiotti R, De Berardis D, Iasevoli F, Torrens M, Di Giannantonio M. Aripiprazole for relapse prevention and craving in alcohol use disorder: current evidence and future perspectives. Expert Opin Inv Drug 2016; 25(6): 719-728. IF 4.408. Q1.

• Nordmann S, Lions C, Vilotitch A, Michel L, Mora M, Spire B, Maradan G, Morel A, Roux P, Carrieri MP, ANRS Methaville study group (...Torrens M...). A prospective, longitudinal study of sleep disturbance and comorbidity in opiate dependence (the ANRS Methaville study). Psychopharmacology (Berl) 2016; 233(7): 1203-13. IF 3.54. Q1.

• Papaseit E, Pérez-Mañá C, Mateus JA, Pujadas-Bastardes M, Fonseca F, Torrens M, Olesti E, de la Torre R, Farré M. Human Pharmacology of Mephedrone in Comparison to MDMA. Neuropsychopharmacology 2016; 41(11): 2704-2713. IF 6.399. Q1.

• Rodríguez-Morató J, Boronat A, Kotronoulas A, Pujadas-Bastardes M, Pastor A, Olesti E, Pérez-Mañá C, Khymenets O, Fitó M, Farré M, de la Torre R. Metabolic disposition and biological significance of simple phenols of dietary origin: hydroxytyrosol and tyrosol. Drug Metab Rev 2016; 48(2): 218-236. IF 4.526. Q1.

• Vallecillo G, Mojal S, Roquer A, Samos P, Luque S, Martínez-Sanvisens D, Martires PK, Torrens M. Low Non-structured Antiretroviral Therapy Interruptions in HIV-Infected Persons Who Inject Drugs Receiving Multidisciplinary Comprehensive HIV Care at an Outpatient Drug Abuse Treatment Center. AIDS Behav 2016; 20(5): 1068-1075. IF 3.063. Q1.

Ongoing Research Projects

• Biomarcadores de consumo de alcohol: evaluación adultos y menores

− Ministerio de Sanidad y Política Social (2013I062)

− From 2014 to 2017

− Principal investigator: Fonseca Casals, Maria Francina

 

• Bases neurobiológicas de la depresión inducida por sustancias de abuso: NEURODEP-2

− Fondo de Investigación Sanitaria. ISCIII (PI12/01838)

− From 2013 to 2017

− Principal investigator: Torrens Melich, Marta

 

• Tratamiento de la dependencia de cocaína con inhibidores de la aldehídodeshidrogenasa (ALDH2)  de origen natural

− Ministerio de Sanidad y Política Social (EC10-166)

− From 2011 to 2017

− Principal investigator: Torrens Melich, Marta

 

• Adaptación de los instrumentos de diagnóstico de patología dual a los criterios DSM-5

− Fondo de Investigación Sanitaria. ISCIII (FIS-PI14/00178)

− From 2015 to 2017

− Principal investigator: Mestre Pintó, Juan Ignacio

 

• Creating medically-driven integrative bioinformatics applications focused on oncology, CNS disorders and their comorbidities (MedBioinformatics)

− (10672) Horizon2020 - Personalising Health and Care - H2020-PHC-2014-two-stage

− From 2015 to 2018

− Principal investigator: Torrens Melich, Marta

 

• EU-MADNESS (EUropean-wide, Monitoring, Analysis and knowledge Dissemination on Novel/Emerging pSychoactiveS): integrated EU NPS monitoring & profiling to prevent health harms and update professionals

− European Commission (JUST/2013/DPIP/AG/4823)

− From 2014 to 2016

− Principal investigator: Torrens Melich, Marta

 

• Neurobiología de la depresión inducida por alcohol: NEURODEP-OH

− Ministerio de Sanidad y Política Social (2012I054)

− From 2012 to 2016

− Principal investigator: Torrens Melich, Marta

Participation in Research Networks

• Red de Trastornos Adictivos

− Fondo de Investigación Sanitaria. Subprograma RETICS. RD12/0028/0009

− Principal investigator: Torrens Melich, Marta

Group’s Recognitions

• Officially recognised as a consolidated research group by the Generalitat de Catalunya: Grup de Recerca en Addiccions (GRAD) (2014-2017)

− Agència de Gestió d’Ajuts Universitaris i de Recerca (SGR 790)

− Principal investigator: Torrens Melich, Marta

Other

• Presentation at Mobile World Congress of e-health app: Dual Diagnosis Screening Interview (DDSI), Barcelona, 2016

C/ Doctor Aiguader, 88

08003 Barcelona

(+34) 93 316 04 00

info@imim.es